康泰医学
(300869)
| 流通市值：41.76亿 | | | 总市值：66.70亿 |
| 流通股本：2.52亿 | | | 总股本：4.02亿 |
| 报告期 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 508,766,739.38 | 752,652,855.64 | 470,525,587.01 | 362,964,487.15 |
| 应收票据及应收账款 | 42,836,340.49 | 40,737,467.88 | 39,863,576.71 | 52,088,842.23 |
| 其中：应收票据 | - | - | - | 1,207,500 |
| 应收账款 | 42,836,340.49 | 40,737,467.88 | 39,863,576.71 | 50,881,342.23 |
| 预付款项 | 9,814,110.85 | 7,140,051.71 | 6,833,726.75 | 12,273,278.63 |
| 其他应收款合计 | 18,688,923.47 | 19,590,340.71 | 7,093,404.07 | 10,893,608.54 |
| 其中:应收利息 | - | - | 0 | - |
| 存货 | 430,089,319.66 | 449,358,544.79 | 463,227,321.97 | 510,787,631.05 |
| 一年内到期的非流动资产 | 162,664,861.14 | 190,644,173.97 | 737,934,721.92 | 935,713,097.26 |
| 其他流动资产 | 4,798,007.21 | 0 | 104,662,294.35 | 101,288,280.7 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,869,207,101.02 | 2,150,686,350.48 | 2,482,164,235.52 | 2,636,067,417.34 |
| 非流动资产: | | | | |
| 投资性房地产 | 16,792,694.31 | 17,176,221.66 | 17,559,749.01 | 17,943,276.36 |
| 固定资产 | 256,325,513.65 | 257,045,761.51 | 261,318,957.06 | 270,211,824.39 |
| 在建工程 | 42,310,556.8 | 26,982,010.56 | 24,549,801.77 | 16,485,877.9 |
| 使用权资产 | 4,727,420.14 | 5,217,204.56 | 4,892,552.77 | 4,466,713.56 |
| 无形资产 | 53,385,110.3 | 54,064,806.65 | 54,744,995.88 | 55,411,465.42 |
| 递延所得税资产 | 7,902,953.7 | 7,492,866.25 | 5,804,961.8 | 1,360,792.34 |
| 其他非流动资产 | 584,175,244.46 | 579,599,320.54 | 360,911,398.36 | 464,284,446.43 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 965,619,493.36 | 947,578,191.73 | 729,782,416.65 | 830,164,396.4 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,834,826,594.38 | 3,098,264,542.21 | 3,211,946,652.17 | 3,466,231,813.74 |
| 流动负债: | | | | |
| 短期借款 | 90,000,000 | 237,000,000 | 347,000,000 | 562,878,400 |
| 应付票据及应付账款 | 19,031,518.26 | 13,996,438.68 | 17,787,231.43 | 22,705,048.45 |
| 应付账款 | 19,031,518.26 | 13,996,438.68 | 17,787,231.43 | 22,705,048.45 |
| 合同负债 | 43,614,953.1 | 42,097,974.9 | 39,966,057.33 | 44,329,845.72 |
| 应付职工薪酬 | 11,825,698.42 | 11,441,319 | 12,330,066.21 | 12,043,732.05 |
| 应交税费 | 6,205,420.69 | 19,666,215.84 | 29,168,942.71 | 38,401,342.68 |
| 其他应付款合计 | 6,977,041.88 | 7,702,678.94 | 11,782,108.67 | 10,380,117.4 |
| 一年内到期的非流动负债 | 1,803,081.98 | 1,691,701.79 | 1,903,671.28 | 1,513,620.71 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 179,457,714.33 | 333,596,329.15 | 459,938,077.63 | 692,252,107.01 |
| 非流动负债: | | | | |
| 应付债券 | 711,709,367.87 | 703,555,829.45 | 695,572,218.11 | 687,488,629.32 |
| 租赁负债 | 2,781,067.02 | 3,320,057.28 | 2,716,347.97 | 2,870,380.53 |
| 递延收益 | 8,373,503.71 | 8,776,398.6 | 8,923,109.29 | 8,005,572.87 |
| 递延所得税负债 | 284.67 | 284.67 | 209.89 | 896,981.77 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 722,864,223.27 | 715,652,570 | 707,211,885.26 | 699,261,564.49 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 902,321,937.6 | 1,049,248,899.15 | 1,167,149,962.89 | 1,391,513,671.5 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 401,802,765 | 401,802,751 | 401,802,671 | 401,802,671 |
| 其他权益工具 | 29,614,253.01 | 29,614,274.09 | 29,614,395.32 | 29,464,357.26 |
| 资本公积 | 345,146,203.51 | 345,145,796.4 | 345,143,472.97 | 345,292,999.08 |
| 其他综合收益 | 3,008,604.91 | 2,794,347.4 | 2,929,610.93 | 3,500,007.21 |
| 盈余公积 | 174,456,618.55 | 174,456,618.55 | 174,456,618.55 | 157,530,943.3 |
| 未分配利润 | 978,476,211.8 | 1,095,201,855.62 | 1,090,849,920.51 | 1,137,127,164.39 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,932,504,656.78 | 2,049,015,643.06 | 2,044,796,689.28 | 2,074,718,142.24 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,932,504,656.78 | 2,049,015,643.06 | 2,044,796,689.28 | 2,074,718,142.24 |
| 负债和股东权益合计 | 2,834,826,594.38 | 3,098,264,542.21 | 3,211,946,652.17 | 3,466,231,813.74 |
| 公告日期 | 2024-08-30 | 2024-04-29 | 2024-04-25 | 2023-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |